Tuesday, June 28 2022   \  Published by Moeller IP Advisors.

Brazil adopts WIPO standard ST.26 on sequence listings

If nucleotide/amino acid sequences are disclosed in a patent application, the description must contain a sequence listing. A sequence listing is a list of biological sequences in the format prescribed by WIPO Standard ST.25 (Presentation of nucleotide and amino acid sequence listings) using controlled vocabulary (i.e., defined terms for certain features). Patent offices may require applicants to file sequence listings in a standardized format when no sequence listing is furnished for the sequences referred to in the description, claims, and/or figures of a patent application. The sequence listing itself recognizes the gene or protein by an "SEQ ID NO" (e.g., SEQ ID NO:1) and provides the complete sequence, which is then made directly accessible in the patent application. Read more

Ready to Get Started?

Contact Sales